Evidence map›Paper›PMID 30985079›Full record

ArticleSmall (Weinheim an der Bergstrasse, Germany)2019

Impact of Locally Administered Carboxydextran-Coated Super-Paramagnetic Iron Nanoparticles on Cellular Immune Function.

Luisa Pedro, Quentin Harmer, Eric Mayes, Jacqueline D Shields

Abstract read
In one paragraph

Article in Small (Weinheim an der Bergstrasse, Germany), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Luisa PedroMRC Cancer Unit, University of Cambridge, Hutchison/MRC Research Centre, Box 197, Cambridge Biomedical Campus, Cambridge, CB2 0XZ, UK.ORCID 0000-0003-0744-8484
Quentin HarmerEndomagnetics Ltd., The Jeffreys Building, St John's Innovation Park, Cowley Road, Cambridge, CB4 0WS, UK.ORCID 0000-0002-0271-3958
Eric MayesEndomagnetics Ltd., The Jeffreys Building, St John's Innovation Park, Cowley Road, Cambridge, CB4 0WS, UK.ORCID 0000-0003-3295-029X
Jacqueline D ShieldsMRC Cancer Unit, University of Cambridge, Hutchison/MRC Research Centre, Box 197, Cambridge Biomedical Campus, Cambridge, CB2 0XZ, UK.ORCID 0000-0003-2153-9710

Funding

Medical Research Council MC_UP_1101/2Medical Research Council MC_UU_12022/5
6 · The paper itself

Abstract

Interstitially administered iron oxide particles are currently used for interoperative localization of sentinel lymph nodes (LNs) in cancer staging. Several studies have described concerns regarding the cellular accumulation of iron oxide nanoparticles relating them to phenotype and function deregulation of macrophages, impairing their ability to mount an appropriate immune response once an insult is present. This study aims to address what phenotypic and functional changes occur during lymphatic transit and accumulation of these particles. Data show that 60 nm carboxydextran-coated iron nanoparticles use a noncellular mechanism to reach the draining LNs and that their accumulation in macrophages induces transient phenotypic and functional changes. Nevertheless, macrophages recover their baseline levels of response within 7 days, and are still able to mount an appropriate response to bacterially induced inflammation.

Indexed as

AnimalsCell LineDextransInflammationMacrophagesMagnetite NanoparticlesMiceMice, Inbred C57BLPhenotypeRAW 264.7 CellsSentinel Lymph NodeDextransferumoxidesMagnetite Nanoparticlesimmune responsemacrophagesentinel lymph node localizationSPIOsuper-paramagnetic iron nanoparticles

Identifiers

PMID30985079
PMCPMC6542677

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.